Search

Your search keyword '"Thromboembolism prevention & control"' showing total 179 results

Search Constraints

Start Over You searched for: Descriptor "Thromboembolism prevention & control" Remove constraint Descriptor: "Thromboembolism prevention & control" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
179 results on '"Thromboembolism prevention & control"'

Search Results

1. Morphology and Function Assessment of Left Atrial Appendage in Patients With Atrial Fibrillation.

2. Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis.

3. Prophylactic intravenous tranexamic acid and thromboembolism in non-cardiac surgery: a systematic review, meta-analysis and trial sequential analysis.

4. Influence of perioperative antiplatelet and anticoagulant medication management on bleeding events in dermatosurgery-A prospective observational study.

5. Retrospective review of secondary prevention strategies for gastrointestinal bleeding and associated clinical outcomes in left ventricular assist device patients.

6. Fixed-dose aspirin monotherapy compared with thromboelastography directed antiplatelet therapy in long-term management of left ventricular assist devices.

7. Is implantable cardioverter defibrillator surgery in patients with an implanted left ventricular assist device safe under uninterrupted oral anticoagulation?

8. Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation.

9. Thromboembolic risk in patients with lung cancer receiving systemic therapy.

10. Alpha-defensins: risk factor for thrombosis in COVID-19 infection.

11. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation.

12. Peri-procedural Anticoagulation in Patients with Head and Neck Versus Extremity Venous Malformations.

13. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.

14. Improved outcomes in CABG patients with atrial fibrillation associated with surgical left atrial appendage exclusion.

15. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management.

16. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.

17. Impact of Blood Pressure Visit-to-Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.

18. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.

19. Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves.

20. Anticoagulation following mitral valve repair.

21. Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?

22. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.

23. Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients.

24. Use of a novel antiplatelet agent cangrelor in an infant supported with a ventricular assist device.

25. Management of Antithrombotic Agents During Surgery or Other Kinds of Medical Procedures With Bleeding: The MARK Study.

26. Long-term discontinuation of warfarin in a patient with HeartMate 3 left ventricular assist device without complication.

27. Omega-3 and hemocompatibility-related adverse events.

28. Risk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study.

29. Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device.

30. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

31. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?

32. Efficacy of tranexamic acid on operative bleeding in endoscopic sinus surgery: A meta-analysis and systematic review.

33. Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens.

34. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.

35. Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion.

36. Should we still be utilizing warfarin in the type 2 diabetic patient?

37. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.

38. Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.

39. Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?

41. Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.

42. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.

43. Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.

44. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.

45. Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

46. Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.

47. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.

48. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events- E uropean R egistry in A trial F ibrillation).

49. Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR ® ) PINNACLE Registry.

50. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.

Catalog

Books, media, physical & digital resources